quantisnow
FeedTopReportsPricing
⌘K
Live feed
17:00:00·35d
PRRelease
AptarGroup Inc. logo

Aptar's Unidose Powder Nasal Delivery System Used in ENA Respiratory Phase II Clinical Study of Investigational INNA‑051 Nasal Spray

ATR· AptarGroup Inc.
Industrials
Original source

Companies

  • ATR
    AptarGroup Inc.
    Industrials

Recent analyst ratings

  • Mar 20UpdateWells Fargo$144.00
  • Jan 6UpdateWells Fargo$133.00
  • Nov 3UpdateWilliam Blair-
  • Sep 4UpdateKeyBanc Capital Markets$220.00
  • Jan 7UpdateRaymond James$200.00
  • Jan 6UpdateBofA Securities$173.00

Related

  • PR16h
    Aptar Declares Quarterly Dividend
  • PR1d
    Aptar Recognized as One of America's Climate Leaders by USA Today for the Fourth Consecutive Year
  • PR15d
    Aptar Digital Health Partners with Enable Injections for enFuse® Companion Digital Solution
  • PR15d
    Aptar Digital Health Partners with Enable Injections for enFuse® Companion Digital Solution
  • SEC28d
    SEC Form DEFA14A filed by AptarGroup Inc.
  • SEC28d
    SEC Form DEF 14A filed by AptarGroup Inc.
  • SEC28d
    Amendment: SEC Form SCHEDULE 13G/A filed by AptarGroup Inc.
  • INSIDER34d
    SEC Form 4 filed by Tlili Hedi
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022